🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Hawaii › Honolulu

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Honolulu, HI

10 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Honolulu (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04928846

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 2
  • Kaiser Permanente Moanalua Medical Center /ID# 272916, Honolulu
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06568939

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • dan 5 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Mengambil pesertaFasa 3
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • dan 4 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • The Queens Medical Center, Honolulu
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06899126

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • dan 6 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06116682

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Mengambil peserta
  • Spark M. Matsunaga VA Medical Center, Honolulu
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT05297734

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Center - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • dan 9 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Mengambil pesertaKajian pemerhatian
  • Hawaii Cancer Care, Honolulu
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT05236114

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Honolulu

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.